Drug Trial Radar · NCT07465289
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Sep 16, 2026
Primary completion
Mar 17, 2031
Study completion Mar 17, 2031
Sponsor
- Lead sponsor
- UCB Biopharma SRLUCB
- Sponsor type
- Industry
- First posted
- Mar 11, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the long-term safety and efficacy of rozanolixizumab in adult study participants with ocular myasthenia gravis.
Conditions
- Ocular Myasthenia Gravis
Interventions
RozanolixizumabDrug
Rozanolixizumab will be administered by subcutaneous infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of treatment-emergent adverse events (TEAEs)Time frame: Up to 2 years
- Incidence of treatment-emergent serious adverse events (TESAEs)Time frame: Up to 2 years
- Incidence of TEAEs leading to permanent withdrawal of study treatmentTime frame: Up to 2 years
Locations
18 sites in 7 countries. Site status is shown where the registry gives one.
Mg0039 10104
Scottsdale, Arizona · Recruiting
Mg0039 10103
Columbus, Ohio · Recruiting
Mg0039 31901
Beijing, China · Recruiting
Mg0039 31912
Beijing, China · Recruiting
Mg0039 31908
Chongqing, China · Recruiting
Mg0039 31907
Nanchang, China · Recruiting
Mg0039 31902
Suzhou, China · Recruiting
Mg0039 20301
Nice, France · Recruiting
Mg0039 21403
Sarajishvili, Georgia · Recruiting
Mg0039 21402
Tbilisi, Georgia · Recruiting
Mg0039 31802
Kobe, Japan · Recruiting
Mg0039 31804
Minatoku, Japan · Recruiting
Mg0039 31805
Sendai, Japan · Recruiting
Mg0039 21206
Lublin, Poland · Recruiting
Mg0039 20604
Barcelona, Spain · Recruiting
Mg0039 20611
Madrid, Spain · Recruiting
Mg0039 20606
Málaga, Spain · Recruiting
Mg0039 20602
Murcia, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.